Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* At least one risk for postpartum hemorrhage and lack of hypersensitivity to oxytocin and carbetocin~Exclusion Criteria:~* Patients' refusal to cooperate, major therapeutic side effects, history of cardiac and renal disease or preeclampsia

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Oxytocin (Type: EXPERIMENTAL): A single 100 microgram IV dose of carbetocin after operation
- Carbetocin (Type: EXPERIMENTAL): A standard 30 international units (IU) IV infusion of oxytocin during two hours

Based on this trial design, predict the completion outcome and termination type (if applicable).